A Double Blind Placebo-controlled Randomized Study of Varicella Zoster Vaccine in Patients With Moderate-to-severe Plaque Psoriasis Who Are Candidates for Biologic Therapy

Trial Profile

A Double Blind Placebo-controlled Randomized Study of Varicella Zoster Vaccine in Patients With Moderate-to-severe Plaque Psoriasis Who Are Candidates for Biologic Therapy

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Plaque psoriasis
  • Focus Pharmacodynamics
  • Sponsors Innovaderm Research
  • Most Recent Events

    • 06 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Mar 2017.
    • 06 Feb 2017 Status changed from recruiting to discontinued.
    • 29 Aug 2016 Planned End Date changed from 1 Jun 2017 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top